CHRONIC KIDNEY DISEASE, DIABETES MELLITUS AND CARDIOVASCULAR DISEASE: RISKS AND COMMONALITIES

SUMMARY The prevalence of chronic kidney disease (CKD) and diabetes mellitus (DM) is increasing worldwide. CKD and diabetes are important risk factors for cardiovascular disease and all three conditions are key components of the multiple morbidities increasingly evident as population age in the deve...

Full description

Saved in:
Bibliographic Details
Published in:Journal of renal care 2012-02, Vol.38 (s1), p.4-11
Main Authors: Suckling, Rebecca, Gallagher, Hugh
Format: Article
Language:English
Subjects:
Cardiovascular disease
Cardiovascular Diseases - complications
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - therapy
Chronic kidney disease
Diabetes Complications - epidemiology
Diabetes Complications - therapy
Diabetes mellitus
Diabetes Mellitus - epidemiology
Diabetes Mellitus - therapy
Diabetic Nephropathies - epidemiology
Diabetic Nephropathies - therapy
Epidemiology
Humans
Nursing
Prevalence
Renal Insufficiency, Chronic - complications
Renal Insufficiency, Chronic - epidemiology
Renal Insufficiency, Chronic - therapy
Risk Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:SUMMARY The prevalence of chronic kidney disease (CKD) and diabetes mellitus (DM) is increasing worldwide. CKD and diabetes are important risk factors for cardiovascular disease and all three conditions are key components of the multiple morbidities increasingly evident as population age in the developed world. Shared risk factors, both traditional and nontraditional, contribute to these associations, and are important targets for public health and both primary and secondary care. Prevention and early detection in combination with a holistic approach to vascular care will be key to improving outcomes and reducing costs. Routine reporting of estimated glomerular filtration rate to aid early identification, risk stratification through quantitative proteinuria testing, appropriate use of renin‐angiotensin system antagonists and optimal blood pressure control are important strategies to improve the care of people with or at risk of CKD.
ISSN:1755-6678
1755-6686
DOI:10.1111/j.1755-6686.2012.00274.x